Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
US Department of Justice

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,643,602

« Back to Dashboard

Summary for Patent: 5,643,602

Title: Oral composition for the treatment of inflammatory bowel disease
Abstract:An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
Inventor(s): Ulmius; Jan (Lund, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/240,078
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Composition; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,643,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8903914Nov 22, 1989

International Patent Family for Patent: 5,643,602

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria125445► Subscribe
Australia643021► Subscribe
Australia7786491► Subscribe
Canada2071518► Subscribe
Germany502092► Subscribe
Germany69021214► Subscribe
Denmark0502092► Subscribe
Egypt19642► Subscribe
European Patent Office0502092► Subscribe
Spain2074698► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus